Sutureless absorbable synthetic implant for large-bore vessel closure (PerQseal)
| Date | Round | Amount |
|---|---|---|
| Mar 2023 | Series D Plus Galway medtech Vivasure Medical received a 30m EUR strategic investment from Haemonetics as part of its Series D round to develop its PerQseal vessel-closure device. | $32.4M |
| May 2022 | Series D Plus Galway medtech Vivasure Medical raised €22m (first part of a Series D up to €52m) led by an unnamed strategic corporation, with Fountain Healthcare and others. | $23.8M |